ECSIT Antikörper (Middle Region)
Kurzübersicht für ECSIT Antikörper (Middle Region) (ABIN925837)
Target
Alle ECSIT Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Middle Region
-
Kreuzreaktivität
- Human, Ratte (Rattus), Hund, Rind (Kuh)
-
Immunogen
- SITPEC antibody was raised in rabbit using the middle region of SITPEC as the immunogen
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
SITPEC Blocking Peptide, catalog no. 33R-4726, is also available for use as a blocking control in assays to test for specificity of this SITPEC antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 100 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Handhabung
- Avoid repeated freeze/thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- ECSIT
-
Andere Bezeichnung
- SITPEC
-
Hintergrund
- Sitpec functions as an essential component in two important signal transduction pathways and establishes a novel role for Ecsit as a cofactor for Smad proteins in the bone morphogenetic protein signaling pathway. Synonyms: Polyclonal SITPEC antibody, Anti-SITPEC antibody.
-
Pathways
- TLR Signalweg, Toll-Like Receptors Cascades, SARS-CoV-2 Protein Interaktom
Target
-